Skip to main content
Log in

In vitro expression of secondary antitumor immunity by in vivo tumor-sensitized T cells: Inhibition by tumor-induced suppressor T cells

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

In vitro cultivation of memory immune cells from P815- or P388-immune mice with corresponding irradiated tumor cells induced generation of cytolytic T cells (CTL). The induction of CTL generation, as well as the cytolytic activity itself, was tumor-specific. The in vitro generation of CTL from P815- or P388-immune cells was suppressed by spleen cells from mice bearing corresponding progressive tumors (tumor size 15 mm). The tumor-induced suppressor cells suppressed the in vitro generation of CTL, but did not affect their cytolytic function. The suppression was tumor-specific and was mediated by Ly1+2L3T4+ T cells. Treatment of suppressor cell donors with cyclophosphamide or sublethal γ-radiation completely abolished the ability of their spleen cells to inhibit the in vitro CTL generation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bear HD (1986) Tumor-specific suppressor T-cells inhibit the in vitro generation of cytolytic T cells from immune and early tumor-bearing host spleens. Cancer Res 46:1805

    Google Scholar 

  2. Berendt MJ, North RJ (1980) T cell-mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 151:69

    Google Scholar 

  3. Bonventre PF, Nikol AD, Ball EJ, Michael JG, Babel HC (1982) Development of protective immunity against bacterial and viral infections in tumor bearing mice coincident with suppression of tumor immunity. J Reticuloendothel Soc 32:25

    Google Scholar 

  4. Bursuker I, North RJ (1985) Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors. Cancer Immunol Immunother 19:215

    Google Scholar 

  5. Dialynas DP, Wilde DB, Marrack M, Pierres A, Wall KA, Havran W, Otten G, Pierres M, Kappler J, Fitch FW (1983) Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate with class II MHC antigen-reactivity. Immunol Rev 74:29

    Google Scholar 

  6. Ledbetter JA, Herzenberg LA (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63

    Google Scholar 

  7. Mark C, Figueroa F, Nagy ZA, Klein J (1982) Cytotoxic monoclonal antibody specific for Lyt-1.2 antigen. Immunogenetics 16:95

    Google Scholar 

  8. Mills CD, North RJ (1983) Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient: Inhibition by suppressor T cells. J Exp Med 157:1448

    Google Scholar 

  9. North RJ (1986) Down-regulation of the antitumor immune response. Adv Cancer Res 45:1

    Google Scholar 

  10. North RJ (1986) Radiation-induced immunologically-mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. J Exp Med 164:1652

    Google Scholar 

  11. North RJ, Bursuker I (1984) Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly1+2 suppressor T cells down-regulate the generation of Ly12+ effector T cells. J Exp Med 159:1295

    Google Scholar 

  12. North RJ, Dye ES (1985) Ly1+2 suppressor T cells down-regulate the generation of Ly12+ effector T cells during progressive growth of the P815 mastocytoma. Immunology 54:47

    Google Scholar 

  13. North RJ, Dye ES, Mills CD (1982) T cell-mediated negative regulation of concomitant antitumor immunity as an obstacle to adoptive immunotherapy of established tumors. In: Fifer F, Goldstein AL (eds) The potential role of T cell populations in cancer therapy. Raven Press, New York, p 65

    Google Scholar 

  14. Raulet DH, Gottlieb PD, Bevan MJ (1980) Fractionation of lymphocyte populations with monoclonal antibodies specific for Lyt2.2 and Lyt3.1. J Immunol 125:1136

    Google Scholar 

  15. Schatten S, Granstein RD, Drebin JA, Green MI (1984) Suppressor T cells and the immune response to tumors. CRC Crit Rev Immunol 4:335

    Google Scholar 

  16. Takei F, Levy JG, Kilburn JG (1976) In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice. J Immunol 116:288

    Google Scholar 

  17. Takei F, Levy JG, Kilburn DG (1976) Characterization of suppressor cells in mice bearing syngeneic mastocytoma. J Immunol 118:412

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaymakcalan, Z., Spitalny, G.L. & Bursuker, I. In vitro expression of secondary antitumor immunity by in vivo tumor-sensitized T cells: Inhibition by tumor-induced suppressor T cells. Cancer Immunol Immunother 25, 69–74 (1987). https://doi.org/10.1007/BF00199943

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199943

Keywords

Navigation